47,191 Shares in Maximus, Inc. $MMS Acquired by Candriam S.C.A.

Key Points

• Candriam S.C.A. acquired 47,191 shares of Maximus, Inc. worth approximately $3.2 million, which constitutes 0.08% of the company's total ownership.
• Maximus reported a quarterly EPS of $2.16, exceeding analysts' estimates, with a revenue of $1.35 billion, reflecting a 2.5% year-over-year increase.
• The company declared a quarterly dividend of $0.30, representing an annualized yield of 1.4%, set to be paid on August 31st.

Candriam S.C.A. purchased a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 47,191 shares of the health services provider's stock, valued at approximately $3,218,000. Candriam S.C.A. owned 0.08% of Maximus as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in MMS. Fuller & Thaler Asset Management Inc. raised its stake in shares of Maximus by 40.0% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock valued at $117,921,000 after acquiring an additional 494,372 shares during the period. SG Capital Management LLC purchased a new stake in shares of Maximus in the 4th quarter valued at approximately $30,285,000. Reinhart Partners LLC. raised its stake in shares of Maximus by 65.4% in the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock valued at $62,156,000 after acquiring an additional 360,365 shares during the period. Boston Partners purchased a new stake in shares of Maximus in the 1st quarter valued at approximately $20,983,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Maximus in the 4th quarter valued at approximately $22,661,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Stock Up 1.5%

Shares of NYSE MMS traded up $1.28 during midday trading on Wednesday, hitting $87.69. The company's stock had a trading volume of 1,068,284 shares, compared to its average volume of 567,260. The business's fifty day simple moving average is $75.18 and its two-hundred day simple moving average is $71.26. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.94. The firm has a market capitalization of $4.94 billion, a price-to-earnings ratio of 16.15 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the firm posted $1.74 earnings per share. The business's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, August 15th. Maximus's dividend payout ratio is presently 22.10%.

Insider Buying and Selling at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of the company's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the sale, the director directly owned 14,205 shares in the company, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.